Otonomy, a clinical-stage bio-pharmaceutical company, has appointed Eric Loumeau as general counsel and chief compliance officer.
Loumeau has over 23 years of experience as in-house legal counsel and compliance officer for several bio-pharmaceutical companies and as outside corporate counsel supporting healthcare and technology-based client companies. Prior to joining Otonomy, Loumeau was the vice president of legal affairs at The Medicines Company, which he joined following the company's acquisition of Rempex Pharmaceuticals.
At Rempex, Loumeau served as vice president, chief financial officer and chief compliance officer and in this capacity he was involved in the completion of several asset acquisitions and financings as well as having primary responsibility for corporate compliance.
Previously, Loumeau also served as general counsel and chief compliance officer for Hollis-Eden Pharmaceuticals, a publicly-traded biotechnology company.